Skip to main content
Glama

Ictrp Search

ictrp_search
Read-onlyIdempotent

Search the WHO International Clinical Trials Registry Platform — one search across ClinicalTrials.gov and the WHO primary registries (ChiCTR China, jRCT/JPRN Japan, CTRI India, IRCT Iran, DRKS Germany, ANZCTR, ISRCTN, EU CTR/CTIS, CRIS Korea, ReBec Brazil, PACTR, TCTR and more). The way to find Chinese, Japanese, Indian and Iranian trials that ClinicalTrials.gov does not carry. Give a free-text query (searches titles, conditions and interventions, with WHO synonym expansion) and/or condition / intervention / sponsor fields; filter by source registry or recruiting status. Each row carries the trial id, its source registry, recruitment status, registration date and the ICTRP record URL — call ictrp_trial for the full record.

Input Schema

NameRequiredDescriptionDefault
limitNoRows to return, 1-100 (default 25).
queryNoFree text, e.g. "psilocybin" or "psilocybin depression". With condition/intervention/sponsor it is matched against the trial TITLE only.
sponsorNoPrimary sponsor name, e.g. "Fudan University".
registryNoKeep only trials from one source registry: CT.gov, ANZCTR, ChiCTR, ITMCTR, CTRI, IRCT, DRKS, jRCT, JPRN, ISRCTN, EU-CTR, CTIS, CRIS, TCTR, PACTR, ReBec, LBCTR, NL-OMON, REPEC, SLCTR, RPCEC. Matched on the trial-id prefix.
conditionNoHealth condition, e.g. "stroke", "type 2 diabetes".
interventionNoIntervention or drug, e.g. "metformin", "acupuncture".
recruiting_onlyNoOnly trials whose status is Recruiting.

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

A4.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, idempotentHint, openWorldHint and destructiveHint=false, so the safety profile is covered. The description adds real behavior beyond that: synonym-expanded free-text matching and the fact that free text narrows to TITLE-only when other fields are supplied, plus what each returned row contains. It stops short of auth/rate-limit or pagination behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Dense but well-organized: the registry enumeration is front-loaded, followed by the differentiating use case, then query mechanics, then return fields. Nothing is redundant, though the long registry list is somewhat padded relative to how an agent would call the tool.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With seven optional parameters, no output schema, and no enums, the description compensates by describing the returned row fields and the query-matching rules. It is complete enough to invoke correctly; only edge cases like result truncation or empty-result behavior are unaddressed.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3, but the description goes beyond the schema by explaining the interaction between query and the condition/intervention/sponsor fields (title-only matching) and the WHO synonym expansion. That is genuine semantic value the schema does not state.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource (search the WHO ICTRP) and immediately scopes it against the obvious alternative by naming the registries ClinicalTrials.gov does not carry. It also explicitly routes the agent to sibling ictrp_trial for the full record, so the boundary between the two tools is unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Gives an explicit selection condition ('The way to find Chinese, Japanese, Indian and Iranian trials that ClinicalTrials.gov does not carry') and names the alternative (ictrp_trial) for deeper detail. It also tells the agent how to build a query (free text and/or condition/intervention/sponsor fields) rather than leaving invocation to inference.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.